65,437 trials
Asthma
Primary: FEV1 (Forced Expiratory Volume in 1 Second) Area Under Curve (AUC) 0-4 Hours After Drug Inhalation — 617.56; 634.64 milliLiters x minutes
Jaw, Edentulous, Partially · Alveolar Bone Loss
Primary: Histologically Measured Bone to Implant Contact (BIC) — 64.552; 54.904 percentage of total surface
Autism
Primary: Group-specific and Comparison of Change in Aberrant Behavior Checklist-Hyperactivity Subscale Score (Active Omega-3 Group Only, Placebo Group Only and Comparison Between…
Diabetes
Primary: Number of Self-Test Fingerstick Blood Glucose (BG) Results Within +/-15mg/dL(<75 mg/dL) or Within +/- 20% (>=75 mg/dL) of Laboratory Glucose Method — 110; 109; 109; 90…
Schizophrenia · Bipolar Disorder
Primary: Percentage of Subjects Experiencing SAEs — 6.2 percentage of participants
Diabetes
Primary: Percentage of Participants Having Remission of Type 2 Diabetes — 76.66 Percentage of Participants
Hypertension
Primary: Percentage of Patients Who Have Achieved Their Pre-specified (Individualized National Heart Foundation of Australia Criteria) Blood Pressure (BP) Target — 27.4; 33.0…
Stable Angina · Heart Failure · Atherosclerosis
Primary: Total Atheroma Volume — 108.2; 115.6; 178 mm3 — p=<0.05
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Peak Expiratory Flow (PEF) 5 Minutes After Morning Dose — 15.1; 13.4 liters/minute
Coronary Artery Disease
Primary: Change From Baseline in Maximum Platelet Aggregation (MPA) to 20 Micromolar (µM) Adenosine Diphosphate (ADP) at Day 12 (Period 1) — 75.00; 76.40; 47.00; 47.00 percent…
Osteoarthritis
Primary: Part A: Number of Participants With Intolerance Events — 0; 0; 0; 0 participants
Age Related Macular Degeneration
Primary: Change From Baseline in Visual-acuity Score (Continuous) — 8.5; 8.0; 6.8; 5.9 No. of Letters — p=0.16
Chronic Obstructive Pulmonary Disease
Primary: Exercise Endurance Time (EET) at 75% of Peak Work Capacity With Cycle Ergometry 1 Hour Post-dose — 529; 441; 406 Seconds
Hereditary Angioedema · Angioneurotic Edema · Genetic Disorders
Primary: Time to Beginning of Relief of Symptoms — 62; 508; 61 minutes — p=0.003
Sudden Cardiac Death
Primary: Defibrillation Thresholds (DFTs) (3.5 ms Waveform) — 427 Volts